Pull Up a Chair with Dr. Freire: The COVID Conversations
Health & Wellness Podcasts
The podcast featured Dr. Maria Freire, past President and Executive Director of the FNIH interviewing researchers and partners working tirelessly to defeat the COVID-19 pandemic. Guests shared their unique perspective on solutions to this deadly virus.
Location:
United States
Genres:
Health & Wellness Podcasts
Description:
The podcast featured Dr. Maria Freire, past President and Executive Director of the FNIH interviewing researchers and partners working tirelessly to defeat the COVID-19 pandemic. Guests shared their unique perspective on solutions to this deadly virus.
Twitter:
@FNIH_Org
Language:
English
Contact:
4103024846
Website:
http://www.fnih.org/
Email:
Wtolentino@fnih.org
Episodes
Interview with Dr. Paul Stoffels, Johnson & Johnson
8/9/2021
Listen in as Dr. Maria Freire explores the work of Dr. Paul Stoffels, Johnson & Johnson’s Vice Chairman of the Executive Committee and Chief Scientific Officer, and his team as they have worked since April 2020 developing COVID-19 vaccines and monitoring emerging variants.
Along with Dr. Francis Collins, Director of NIH, Dr. Stoffels co-chairs Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), the historic public-private partnership created to combat COVID-19 on all fronts.
Duration:00:33:57
Interview with Dr. Anne Schuchat, Principal Deputy Director of the Centers for Disease Control and Prevention
6/3/2021
In this episode, Dr. Maria Freire sits down with Dr. Anne Schuchat, Principal Deputy Director of the Centers for Disease Control and Prevention. Learn how the CDC evaluates data when issuing guidance to the public, as well as its role in surveillance of new COVID-19 variants. According to Dr. Schuchat, “It’s part of our national security to worry about these pathogens around the world, and nothing has illustrated this more clearly than COVID-19."
Duration:00:35:08
Interview with David Wholley, FNIH
5/6/2021
What is ACTIV and why is it so important to the public? Listen as Dr. Maria Freire, President and Executive Director of the FNIH sits down with David Wholley, the FNIH's Senior Vice President of Research Partnerships, to tell the story of how the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership came together with urgency to address the COVID-19 crisis. Learn about how the FNIH guided the efforts of multiple U.S. government agencies, not-for-profit organizations and industry partners, all working together to develop COVID-19 vaccines and treatments.
Duration:00:32:53
Interview with Dr. Mikael Dolsten, Pfizer
4/20/2021
Dr. Freire sits down with Dr. Mikael Dolsten, Chief Scientific Officer and President of Worldwide Research, Development and Medical of Pfizer, Inc. They explore the approach to and challenges associated with developing the Pfizer-BioNtech COVID 19 vaccine, research efforts on potential treatments and promising new therapeutics for the future.
Duration:00:30:46
Interview with Dr. Francis Collins, National Institutes of Health Director
3/29/2021
Dr. Freire engages in a conversation with Dr. Francis Collins, NIH Director, around the incredible acceleration of biomedical research that was needed to get ahead of the COVID-19 crisis. They describe how the historic Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership convened government agencies, not-for-profit organizations and 20 pharmaceutical companies to research successful therapeutics and vet promising vaccines.
Duration:00:32:32
Interview with Drs. Mary Beth Harler and Robert Plenge from Bristol Myers Squibb
2/25/2021
Dr. Freire hosts an engaging and informative conversation with two scientists from Bristol Myers Squibb: Dr. Mary Beth Harler and Dr. Robert Plenge. Learn how treatments for COVID-19 are addressed along the continuum from initial work in the lab to patient care. Drs. Freire, Harler and Plenge also discuss the importance of looking at the biology of this virus to identify the best treatment options.
Dr. Mary Beth Harler is Senior Vice President, Head of Immunology & Fibrosis Development, Global Drug Development and Dr. Robert Plenge is Senior Vice President, Research & Early Development and Head of the Immunology, Cardiovascular, Fibrosis, and Global Health Thematic Research Center team of Bristol Myers Squibb.
Duration:00:33:04
Interview with Dr. Janet Woodcock
2/8/2021
Dr. Freire engages in a lively and eye-opening conversation with Dr. Janet Woodcock, acting commissioner of the Food and Drug Administration. Drs. Freire and Woodcock explore the process to move drug candidates effectively and safely from clinical trials to market. Learn how it happened so quickly and what it means for you.
Duration:00:29:13